Table 3.
Annual drug acquisition costs (2005)
Drugs | Annual acquisition costs (wholesale) of drugs ($S) |
---|---|
LAM | 2774.00 |
ADF | 3606.20 |
IFN* | 7329.75 |
PEG-IFN† | 20 740.00 |
LAM, lamivudine; PEG-IFN, pegylated-interferon; ADF, adefovir.
IFN costs are the average for Roferon-A and Intron-A (range of doses) and 6–12 months treatment durations.
PEG-IFN costs are the average of those for Pegasys and Peg-Intron for a duration of 12 months.